Join us on March 7 for our Educated Patient Summit on Breast Cancer taking place in Miami, FL! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Gastrointestinal stromal tumor

Conor Killmurray
Patients with gastrointestinal stromal tumors have a new targeted therapy that looks to tackle secondary mutations after it showed a strong response rate in the clinic.
 
Conor Killmurray
The Food and Drug Administration approved Ayvakit for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumor who exhibited a platelet-derived growth factor receptor alpha exon 18 mutation.
 
Erik Ness
How zeroing in on the mutation in gastrointestinal stromal tumors is adding years to patients’ lives
Brielle Urciuoli
The Life Raft Group, a patient advocacy organization, is teaming up with research organizations to hopefully find the next wave of treatment for patients with gastrointestinal stromal tumors.
Heather Millar
Identified only a decade-and-a-half ago, GIST is already treatable with several targeted therapies, and scientists are researching more.
Melissa D. Shepherd
Melissa D. Shepherd, an acute care nurse practitioner from the Huntsman Cancer Institute in Salt Lake City, Utah, discusses side effects associated with second- and third-line treatments for GIST.
Melissa Shepherd
Melissa Shepherd, an acute care nurse practitioner from the Huntsman Cancer Institute in Salt Lake City, Utah, discusses side effects associated with treatment for gastrointestinal stromal tumors (GIST).
Melissa D. Shepherd
Melissa D. Shepherd, Acute Care Nurse Practitioner, Huntsman Cancer Institute, discusses the various players involved in the care of a patient with GIST (gastrointestinal stromal tumors).
Melissa D. Shepherd
Melissa D. Shepherd, describes what gastrointestinal stromal tumors (GIST) are —┬átumors that arise in the esophagus, stomach, small bowel, large bowel or the rectum.
Moving back into the light.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×